Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00240110 · ClinicalTrials.gov registry record · Phase 1
Valproate Efficacy in Cocaine-Bipolar Comorbidity
A Phase 1 study of Bipolar Disorder and Cocaine Dependence, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 152
- Enrollment target
- 2
- Study locations
NCT00240110 is a Phase 1 study of Bipolar Disorder and Cocaine Dependence that has completed, run by University of Miami. The registered enrollment target is 152 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00240110, a Phase 1 study of Bipolar Disorder and Cocaine Dependence, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 152 participants
- Enrollment target
- 2
- Study locations
Study Summary
This proposal will test the efficacy of a promising pharmacological approach for the treatment of comorbid cocaine dependence and bipolar disorder. We propose a randomized, double blind, placebo controlled 12-week trial to test the efficacy of Divalproex sodium (Valproate) plus treatment as usual compared to placebo plus treatment as usual in decreasing cocaine use and stabilizing mood symptoms among patients with comorbid cocaine dependence and bipolar disorder. Treatment as usual includes the use of lithium carbonate for mood stabilization plus supportive psychosocial treatment.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Valproate
- DRUG Lithium Carbonate
Study Locations (2)
Florida
- University of Miami Miller School of Medicine, Department of Psychiatry - Miami
- University of Miami Miller School of Medicine - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2006-03 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00240110
The ClinicalTrials.gov registry entry for NCT00240110 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (54% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00240110 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00240110 about?
NCT00240110 is a clinical study titled "Valproate Efficacy in Cocaine-Bipolar Comorbidity". This proposal will test the efficacy of a promising pharmacological approach for the treatment of comorbid cocaine dependence and bipolar disorder. We propose a randomized, double blind, placebo controlled 12-week trial to test the efficacy of Divalproex sodium (Valproate) plus treatment as usual co...
What is the current status of trial NCT00240110?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 152 participants. The study started on 2006-03. Estimated completion is 2014-03.
What conditions does trial NCT00240110 study?
This clinical trial studies the following conditions: Bipolar Disorder, Cocaine Dependence.
What interventions are being tested in trial NCT00240110?
The interventions under investigation include: Placebo (DRUG), Valproate (DRUG), Lithium Carbonate (DRUG).
Who is sponsoring clinical trial NCT00240110?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00240110 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder
COMPLETED · Phase 1
-
Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
COMPLETED · Phase 1
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.